263 related articles for article (PubMed ID: 20689132)
21. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
[TBL] [Abstract][Full Text] [Related]
22. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
23. The discovery and validation of colorectal cancer biomarkers.
Ang CS; Phung J; Nice EC
Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
[TBL] [Abstract][Full Text] [Related]
24. Early diagnosis and predictors of malignancy of adnexal masses.
Murta EF; Nomelini RS
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):14-9. PubMed ID: 16493254
[TBL] [Abstract][Full Text] [Related]
25. Proteomic approaches in lung cancer biomarker development.
Cho JY; Sung HJ
Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
[TBL] [Abstract][Full Text] [Related]
26. Recent technical strategies to identify diagnostic biomarkers for ovarian cancer.
Ye B; Gagnon A; Mok SC
Expert Rev Proteomics; 2007 Feb; 4(1):121-31. PubMed ID: 17288520
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
[TBL] [Abstract][Full Text] [Related]
28. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.
Leung F; Diamandis EP; Kulasingam V
Adv Clin Chem; 2014; 66():25-77. PubMed ID: 25344985
[TBL] [Abstract][Full Text] [Related]
30. Urinary proteomics--a tool for biomarker discovery.
Pejcic M; Stojnev S; Stefanovic V
Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
[TBL] [Abstract][Full Text] [Related]
31. Proteomics-driven cancer biomarker discovery: looking to the future.
Simpson RJ; Bernhard OK; Greening DW; Moritz RL
Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
[TBL] [Abstract][Full Text] [Related]
32. Proteomic approaches for serum biomarker discovery in cancer.
Maurya P; Meleady P; Dowling P; Clynes M
Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
[TBL] [Abstract][Full Text] [Related]
33. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.
Elschenbroich S; Ignatchenko V; Clarke B; Kalloger SE; Boutros PC; Gramolini AO; Shaw P; Jurisica I; Kislinger T
J Proteome Res; 2011 May; 10(5):2286-99. PubMed ID: 21491939
[TBL] [Abstract][Full Text] [Related]
34. Cancer biomarkers: current issues and future directions.
Jain KK
Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
[TBL] [Abstract][Full Text] [Related]
35. Proteomic profiling of peritoneal rinse fluid sediment separates patients with ovarian cancer from women admitted for cesarean section. A pilot study.
Honoré B; Vorum H; Knudsen A
Scand J Clin Lab Invest; 2010 Nov; 70(7):470-7. PubMed ID: 20704521
[TBL] [Abstract][Full Text] [Related]
36. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
[TBL] [Abstract][Full Text] [Related]
37. [Molecular diagnostics of ovarian cancer using proteome techniques].
Vlasova MA; Moshkovskiĭ SA; Safarova MP; Makarov OV; Archakov AI
Biomed Khim; 2005; 51(4):367-83. PubMed ID: 16223028
[TBL] [Abstract][Full Text] [Related]
38. Molecular predictors of response and outcome in ovarian cancer.
Canevari S; Gariboldi M; Reid JF; Bongarzone I; Pierotti MA
Crit Rev Oncol Hematol; 2006 Oct; 60(1):19-37. PubMed ID: 16829123
[TBL] [Abstract][Full Text] [Related]
39. Mass spectrometry: uncovering the cancer proteome for diagnostics.
van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
[TBL] [Abstract][Full Text] [Related]
40. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]